Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (161-170 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|August 17, 2014
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)Robert K Flamm, Helio S Sader, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United StatesRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Results from the Solithromycin International Surveillance Program (2014)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2016
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014)Helio S Sader, Rodrigo E Mendes, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwideHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Michael A Pfaller, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|April 25, 2006
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|March 8, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Memorias Do Instituto Oswaldo Cruz|November 23, 2005
Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002)Ana C Gales, Ronald N Jones, Soraya S Andrade, et al.
Pageof 42

Showing results (161-170 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|August 17, 2014
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)Robert K Flamm, Helio S Sader, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United StatesRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Results from the Solithromycin International Surveillance Program (2014)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2016
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014)Helio S Sader, Rodrigo E Mendes, Ronald N Jones, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2004
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwideHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Michael A Pfaller, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|April 25, 2006
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
International Journal of Antimicrobial Agents|March 8, 2013
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 9, 2013
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)David J Farrell, Robert K Flamm, Helio S Sader, et al.
Memorias Do Instituto Oswaldo Cruz|November 23, 2005
Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002)Ana C Gales, Ronald N Jones, Soraya S Andrade, et al.
Pageof 42